Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

• Mirte Scherpenisse ,

  * E-mail: Mirte.Scherpenisse@rivm.nl

  Affiliations Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands

  ⨯
• Madelief Mollers,

  Affiliations Department of Epidemiology and Surveillance, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands

  ⨯
• Rutger M. Schepp,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Hein J. Boot,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Chris J. L. M. Meijer,

  Affiliation Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands

  ⨯
• Guy A. M. Berbers,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Fiona R. M. van der Klis,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Hester E. de Melker

  Affiliation Department of Epidemiology and Surveillance, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯